171 related articles for article (PubMed ID: 27861291)
41. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
42. Human epidermal Langerhans cells replenish skin xenografts and are depleted by alloreactive T cells in vivo.
Hemmerling J; Wegner-Kops J; von Stebut E; Wolff D; Wagner EM; Hartwig UF; André MC; Theobald M; Schopf RE; Herr W; Meyer RG
J Immunol; 2011 Aug; 187(3):1142-9. PubMed ID: 21697461
[TBL] [Abstract][Full Text] [Related]
43. Effect of epigallocatechin-3-gallate on graft-versus-host disease.
Choi J; Cooper ML; Ziga ED; Ritchey J; DiPersio JF
Cell Transplant; 2014; 23(9):1163-6. PubMed ID: 23676554
[TBL] [Abstract][Full Text] [Related]
44. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
45. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
[TBL] [Abstract][Full Text] [Related]
46. [Animal model of immunologic change detection in vivo after xenotransplantation].
Zhang HT; Li YP
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 May; 16(3):205-8. PubMed ID: 12569700
[TBL] [Abstract][Full Text] [Related]
47. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J; Subbiah S; Lazarus HM; van Besien K
Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
[TBL] [Abstract][Full Text] [Related]
48. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
49. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Sairafi D; Stikvoort A; Gertow J; Mattsson J; Uhlin M
J Immunol Res; 2016; 2016():5601204. PubMed ID: 27965986
[No Abstract] [Full Text] [Related]
50. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
51. Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.
Mutis T; van Rijn RS; Simonetti ER; Aarts-Riemens T; Emmelot ME; van Bloois L; Martens A; Verdonck LF; Ebeling SB
Clin Cancer Res; 2006 Sep; 12(18):5520-5. PubMed ID: 17000688
[TBL] [Abstract][Full Text] [Related]
52. Insights into the pathogenesis of GvHD: what mice can teach us about man.
Hülsdünker J; Zeiser R
Tissue Antigens; 2015 Jan; 85(1):2-9. PubMed ID: 25532439
[TBL] [Abstract][Full Text] [Related]
53. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
[TBL] [Abstract][Full Text] [Related]
54. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
55. Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.
Furlan SN; Watkins B; Tkachev V; Cooley S; Panoskaltsis-Mortari A; Betz K; Brown M; Hunt DJ; Schell JB; Zeleski K; Yu A; Giver CR; Waller EK; Miller JS; Blazar BR; Kean LS
Blood; 2016 Nov; 128(21):2568-2579. PubMed ID: 27758873
[TBL] [Abstract][Full Text] [Related]
56. Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells.
Haque M; Boardman DA; Lam AJ; MacDonald KN; Sanderink L; Huang Q; Fung VCW; Ivison S; Mojibian M; Levings MK
Bio Protoc; 2022 Dec; 12(23):. PubMed ID: 36561116
[TBL] [Abstract][Full Text] [Related]
57. Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.
Morelli AE; Larregina AT
Stem Cells; 2016 May; 34(5):1142-50. PubMed ID: 26865545
[TBL] [Abstract][Full Text] [Related]
58. [Animal models in the study of allogeneic hematopoietic stem cell transplantation].
Hashimoto D
Rinsho Ketsueki; 2020; 61(4):369-378. PubMed ID: 32378583
[TBL] [Abstract][Full Text] [Related]
59. Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR.
Seng A; Markiewicz MA
J Vis Exp; 2019 May; (147):. PubMed ID: 31180340
[TBL] [Abstract][Full Text] [Related]
60. Immunotherapeutic strategies in autoimmune uveitis.
Papotto PH; Marengo EB; Sardinha LR; Goldberg AC; Rizzo LV
Autoimmun Rev; 2014 Sep; 13(9):909-16. PubMed ID: 24833504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
